Ensign Peak Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $785K | Hold |
|
|||||
|
2025
Q1 | $815K | Hold |
|
|||||
|
2024
Q4 | $900K | Hold |
|
|||||
|
2024
Q3 | $776K | Hold |
|
|||||
|
2024
Q2 | $666K | Hold |
|
|||||
|
2024
Q1 | $849K | Sell |
|
|||||
|
2023
Q4 | $757K | Hold |
|
|||||
|
2023
Q3 | $721K | Hold |
|
|||||
|
2023
Q2 | $786K | Hold |
|
|||||
|
2023
Q1 | $947K | Hold |
|
|||||
|
2022
Q4 | $933K | Buy |
|
|||||
|
2022
Q3 | $655K | Hold |
|
|||||
|
2022
Q2 | $559K | Hold |
|
|||||
|
2022
Q1 | $625K | Hold |
|
|||||
|
2021
Q4 | $564K | Sell |
|
|||||
|
2021
Q3 | $1.34M | Hold |
|
|||||
|
2021
Q2 | $1.54M | Hold |
|
|||||
|
2021
Q1 | $1.31M | Hold |
|
|||||
|
2020
Q4 | $1.26M | Sell |
|
|||||
|
2020
Q3 | $1.09M | Hold |
|
|||||
|
2020
Q2 | $1.25M | Hold |
|
|||||
|
2020
Q1 | $944K | Buy |
|
|||||
|
2019
Q4 | $1.22M | Buy |
|